News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Donoghoe Nicholas
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/10/2023 |
3
| Donoghoe Nicholas (EVP, Chief Bus/Strat Officer) has filed a Form 3 on AbbVie Inc. |
| 03/03/2020 |
4
| Donoghoe Nicholas (SVP, Enterprise Innovation) has filed a Form 4 on AbbVie Inc.|
Txns:
| Paid exercise price by delivering 2,355 shares
@ $85.42, valued at
$201.2k
|
|
| 02/24/2020 |
4
| Donoghoe Nicholas (SVP, Enterprise Innovation) has filed a Form 4 on AbbVie Inc.|
Txns:
| Granted 5,316 shares
@ $0
Granted 72,013 options to buy
@ $93.5, valued at
$6.7M
|
|
| 01/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/30/2019 |
4
| Donoghoe Nicholas (SVP, Enterprise Innovation) has filed a Form 4 on AbbVie Inc.|
Txns:
| Bought 7,525 shares
@ $66.187, valued at
$498.1k
|
|
| 02/22/2019 |
4
| Donoghoe Nicholas (SVP, Enterprise Innovation) has filed a Form 4 on AbbVie Inc.|
Txns:
| Granted 32,710 options to buy
@ $79.02, valued at
$2.6M
|
|
| 01/04/2019 |
4
| Donoghoe Nicholas (SVP, Enterprise Innovation) has filed a Form 4 on AbbVie Inc.|
Txns:
| Granted 5,565 shares
@ $0 |
|
| 01/04/2019 |
3
| Donoghoe Nicholas (SVP, Enterprise Innovation) has filed a Form 3 on AbbVie Inc. |
|
|